Although some studies have indicated atheroprotective role of IL-33 to reduces plaque size (McLaren et al. 2010), other studies have shown IL-33-ST2 levels are increased in patients with carotid atherosclerosis (Stankovic et al. 2019). This evidence concerns the gene IL1RL1 and carotid atherosclerosis.